Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib
Public ClinicalTrials.gov record NCT01831726. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 2 - Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib Including Tumors With Mutations or Translocations of FGFR, PDGFR, VEGF, cKIT, FLT3, CSFR1, Trk and RET
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this signal seeking study was to determine whether treatment with dovitinib (TKI258) demonstrated sufficient efficacy in select pathway-activated solid tumors and/or hematologic malignancies to warrant further study.
Study identification
- NCT ID
- NCT01831726
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 80 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2013 (Type not available)
- Primary completion
- Dec 2015 (Actual)
- Completion
- Dec 2015 (Actual)
- Last update posted
- Mar 20, 2017
2013 – 2015
United States locations
- U.S. sites
- 49
- U.S. states
- 27
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Oncology | Birmingham | Alabama | 35211 | — |
| Highlands Oncology Group SC | Fayetteville | Arkansas | 72703 | — |
| PCR Oncology | Pismo Beach | California | 93449 | — |
| Sarcoma Oncology Center | Santa Monica | California | 90403 | — |
| Rocky Mountain Cancer Centers Rocky Mountain Cancer Centers | Greenwood Village | Colorado | — | — |
| Whittingham Cancer Center Norwalk Hospital | Norwalk | Connecticut | 06856 | — |
| Memorial Cancer Institute Memorial Healthcare System | Hollywod | Florida | 33021 | — |
| Cancer Specialists of North Florida Cancer Specialists (2) | Jacksonville | Florida | 32256 | — |
| Florida Hospital Cancer Institute | Orlando | Florida | 32804 | — |
| Space Coast Medical Associates Space Coast Cancer Center | Titusville | Florida | 32796 | — |
| University Cancer & Blood Center, LLC | Athens | Georgia | 30607 | — |
| NorthWest Georgia Oncology Centers NW Georgia Oncology | Marietta | Georgia | 30060 | — |
| Lurie Children's Hospital of Chicago Developmental Therapeutics | Chicago | Illinois | 60611 | — |
| Illinois Cancer Care | Peoria | Illinois | 61615-7828 | — |
| Indiana University Indiana Univ. - Purdue Univ. | Indianapolis | Indiana | 46202 | — |
| Horizon Oncology Center Horizon Oncology Ctr. | Lafayette | Indiana | 47905 | — |
| St. Agnes Hospital St. Agnes Hospital (2) | Baltimore | Maryland | 21229 | — |
| University of Michigan Int. Medicine Oncology | Ann Arbor | Michigan | 48109 | — |
| Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology | Minneapolis | Minnesota | 55404 | — |
| Billings Clinic Onc Dept | Billings | Montana | 59107 | — |
| Southeast Nebraska Oncology Cancer Center | Lincoln | Nebraska | 68510 | — |
| Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2) | Las Vegas | Nevada | 89109 | — |
| Waverly Hematology Oncology | Cary | North Carolina | 27518 | — |
| Oncology Hematology Care, Inc. Oncology Hematology Care (2) | Cincinnati | Ohio | 45242 | — |
| Cleveland Clinic Foundation Cleveland Clinic (19) | Cleveland | Ohio | 44195 | — |
| St. Charles Cancer Center | Bend | Oregon | 97701 | — |
| Oregon Health & Science University OHSU Knight Cancer Institute | Portland | Oregon | 97239 | — |
| University of Pittsburgh Cancer Institute | Pittsburgh | Pennsylvania | 15232-1305 | — |
| Rhode Island Hospital Rhode Island Hosp. (2) | Providence | Rhode Island | 02903 | — |
| Gibbs Cancer Center & Research Institute Spartanburg Reg. Healthcare | Spartanburg | South Carolina | 29303 | — |
| Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology | Chattanooga | Tennessee | 37404 | — |
| The West Clinic | Memphis | Tennessee | 38120 | — |
| Sarah Cannon Research Institute Tennessee Oncology | Nashville | Tennessee | 37203 | — |
| Austin Cancer Centers Austin Cancer Center (2) | Austin | Texas | 78759 | — |
| Texas Oncology Texas Oncology - Sammons | Dallas | Texas | 75246 | — |
| Texas Oncology Midtown Texas Oncology | Dallas | Texas | 75251 | — |
| The Center for Cancer and Blood Disorders | Fort Worth | Texas | 76104 | — |
| Oncology Consultants Oncology Group | Houston | Texas | 77024 | — |
| MD Anderson Cancer Center/University of Texas MD Anderson Cancer Center (3) | Houston | Texas | 77030 | — |
| Tyler Cancer Center | Tyler | Texas | 75702 | — |
| Intermountain Medical Center Intermountain Healthcare | Murray | Utah | 84157 | — |
| Virginia Cancer Specialists Virginia Cancer Specialists | Fairfax | Virginia | 22031 | — |
| Providence Regional Cancer Partnership Providence Reg. Cancer (2) | Everett | Washington | 98201 | — |
| Evergreen Hematology & Oncology | Spokane | Washington | 99218 | — |
| Northwest Medical Specialties Hematology/Oncology | Tacoma | Washington | 98405 | — |
| Wenatchee Valley Medical Center Wenatchee Valley | Wenatchee | Washington | 98801 | — |
| Yakima Valley Memorial Hospital North Star Lodge Cancer Center | Yakima | Washington | 98902 | — |
| Aurora Research Institute | Milwaukee | Wisconsin | 53226 | — |
| Medical College of Wisconsin Cancer Ctr.-Froedtert Hospital | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01831726, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 20, 2017 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01831726 live on ClinicalTrials.gov.